LET’S HACK THE CODE!
Just six decades after Orville and Wilbur Wright launched the aviation age, President Kennedy pronounced a moonshot: fly people to the moon and back. Eight years later, the mission was accomplished. Now, six decades after James Watson and Francis Crick discovered the code of life, it is time to embark on another historic mission: hack the code of life and cure aging.
PALO ALTO PRIZE – TEAM APPROACH
There are two prizes available and teams may compete for one or both prizes:
• A $500,000 Longevity Demonstration Prize will be awarded to the first Team that meets all the requirements of the Prize Requirements as determined by the Judging Panel in its sole discretion, including extending the mean lifespan of a wild-type mammalian intervention cohort by 50% relative to acceptable published natural history of untreated norms in a statistically significant (p<.05) manner, using a Statistical Model (as defined and approved in the official “Competition Agreement”). The intervention and control cohorts should be age and gender matched and should include an equal number of males and females. If you would like more details on the Prize Requirements please use the contact form at the bottom of this page.
Each team participating in the Prize is responsible for funding 100% of its participation in the Prize including all research and development costs and publishing its work and/or the reproduction of results. To enable a rapid commercial path forward for the innovations, the sponsor of the Prize will be contributing an existing pool of relevant intellectual property to the Prize effort.
PALO ALTO PRIZE – PERSONAL STORIES
Sign up today!
LET’S DO THIS!
WHY A PRIZE?
Incentive prizes work because they attract:
Prizes attract the best minds to focus on finding solutions to a specific area of innovation. From researchers at universities, to startups, to small teams within larger companies, prizes create a target for innovators to try to solve. Prize purses, advanced market commitments, and the glory of winning helps “pull” innovation in a specific direction. By creating a new playing field, prizes also help pull everyone together toward the common goal.
Everyone loves a competition and everyone loves heroes, especially the media! When crafted and produced well, incentive prizes are a great way to tell stories and to educate the public about the area of discovery. They also provide a wonderful medium to create heroes out of the hard-working teams that make it happen.
Once you have the best minds in the world focusing on a breakthrough area, capital will follow. Angel investors, venture capital funds, and the venture arms of corporations are always looking for the next breakthrough area and teams to invest in. Prizes help unearth who those teams are, and what they are working on related to the prize, and other products, services and intellectual property that they might have that are not related to the prize.
Now is the time to launch this prize, because we have reached the point in science, where we really do have the opportunity to solve aging.Dr. Doris Taylor
The Palo Alto Prize enables us to attack moonshot problemsJin Lee
Give nature the tools and get out of the wayDoris Taylor
We have the foundations that will allow us to live to 120 and we can do it.David Mendelowitz
The race against time is imminent. We need to act nowDavid Mendelowitz
Every moment of our life is a race against timeJin Lee
The longer people live and the more productive they are the more they contribute to societyIrving Zucker
We’ve reached a point in science where we really do have the opportunity to solve agingDoris Taylor
You never change things by fighting the existing reality. To change something, build a new model that makes the existing model obsolete.R. Buckminster Fuller
If you keep us in this room long enough, we will solve agingDr. Doris Taylor
Give nature the tools and get out of the way.Dr. Doris Taylor
We have to reinvent ourselves to make progressIrving Zucker
VICTOR DZAU, M.D.
President of the Institute of Medicine
LEONARD GUARENTE, Ph.D.
Director, Glenn Laboratory for the Science of Aging at MIT
Dr. STUART KIM, Ph.D
Professor, Depts. of Developmental Biology and Genetics
Stanford University Medical Center
DAVID SINCLAIR, Ph.D.
Professor, Genetics Dept. Harvard Medical School
JOHN SEDIVY Ph.D.
Brown Faculty, Department of Molecular Biology, Cell Biology, and Biochemistry
KEITH BLACKWELL, M.D, Ph.D.
Principal Investigator, The Blackwell Lab at the Joslin Diabetes Center
President and CEO
Alliance for Aging Research
RUSSEL J. REITER, Ph.D., Dr.H.C.MULT.
Professor of Cell Biology, UT Health Science Center
Managing Director, Draper Fisher Jurvetson
Founder, Hidary Foundation
FRANK LONGO, M.D.
Professor and Chair, Department of Neurology and Neurological Sciences, Stanford University
CHARLES CHO, M.D.
Professor of Neurology and Neurosurgery, Stanford University
ERIC VERDIN, M.D.
Senior Investigator, Gladstone Institute of Virology and Immunology Professor, UCSF School of Medicine
Executive Director – Mprize, Methuselah Foundation
Author, 100 Plus
President, Engaged Partners (Frm. EVP of Strategy, X PRIZE Foundation)
GUY P. NOHRA
Co-Founder and Managing Director, Alta Partners
Associate Founder, Singularity University; Trustee, Santa Fe Institute
FEDERICK J. DOTZLER
Managing Director, De Novo Ventures
Managing Director, Interwest Ventures
Founder, Longevity Fund
Managing Director, General Catalyst Partners
General Partner, Foundation Capital
Managing Director, Versant Ventures
GARHENG KONG, M.D., MBA
Managing General Partner, Sofinova Ventures
Founder and Managing Director, Longitude Capital
JIM GLASHEEN, PH.D.
General Partner, Technology Partners
ROGER J. QUY, PH.D.
General Partner, Technology Partners
Partner, Third Rock Ventures Patrick-Enright
JOSH MAKOWER, M.D.
Founder and CEO, ExploraMed
Assistant Managing Editor, Forbes
President and CEO of Stanford Hospital & Clinic
BARBARA J. NATTERSON-HOROWITZ, M.D.
Professor of Medicine, UCLA Division of Cardiology
President and CEO, Cyberonics, Inc.
General Partner, Google Ventures, Trustee, Santa Fe Institute
BOB HARRINGTON, M.D.
Chairman, Department of Medicine, Stanford University
Associate Vice Chancellor, University Relations, UC San Francisco
AUBREY DE GREY, MA, PH.D
Ph.D, Chief Science Officer, SENS Foundation
VALTER LONGO, PH.D.
Director, USC Longevity Institute
BEN BARRES, M.D., PH.D.
Chairman, Department of Neurobiology, Stanford University
President and CEO, Neuropace, Inc.
JAMES R. DOTY, M.D.
Professor of Neurosurgery, Stanford University Founder and Director of CCARE
ALAN GREENE, MD
Author, Pediatrician, Founding President of the Society of Participatory Medicine
CEO and President, The Buck Institute for Research on Aging
LEIGHTON READ, M.D.
Venture Partner, Alloy Ventures
Managing Director, Konus Advisory Group
Managing Partner, Vivo Ventures
MICHAEL MCCULLOUGH, M.D.
Principal, Capricorn Healthcare & Special Opportunities
Director, Digital Content Strategy, Palo Alto Investors
Partner, Norwest Venture Partners
Managing Director, Versant Ventures
Managing Partner, EcoR1 Capital
Director, Healthcare Practice at IDEO
WAYNE B. JONAS, M.D.
President & CEO Samueli Institute
The Palo Alto Prize is a newly established Silicon Valley-based initiative of the Race Against Time Foundation. The mission of the Palo Alto Prize is to encourage collaboration, foster innovation, and build a community to address the underlying causes of aging. In addition to the $1 million of cash prizes, the Palo Alto Prize is also working with a number of angel investors, venture capital firms, corporate venture arms, institutions and private foundations to provide access to additional capital to the teams during the competition. While the Palo Alto Prize will help facilitate introductions, all transactions and due diligence will be done privately between the teams and potential investors and philanthropists.
The Race Against Time (dba The Hero Science Foundation www.herosf.org) is a 501(c)(3) educational non-profit organization (Tax ID: 47-2823482) created to raise public awareness and financial support for basic biomedical research related to increasing our health span and defining the fundamental biological mechanisms that prevent age-related diseases and disabilities.
About the prize sponsor:
Dr. Joon Yun, M.D., is the President of Palo Alto Investors, LLC, founded in 1989 with over $2 billion in assets under management invested in healthcare and the founder of the Palo Alto Institute, a nonprofit think-tank that has been providing operational support for the Palo Alto Prize. Board certified in radiology, Dr. Yun served on the clinical staff at Stanford Hospital from 2000-2006. Dr. Yun received his Bachelor of Arts in biology from Harvard University and his Doctor of Medicine from Duke University School of Medicine. Learn more at DrJoonYun.com and follow him at @drjoonyun